Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 83.95 | (625.78) | (461.47)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 136.14 | (667.00) | (487.95)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 373.07 | (469.82) | (322.43)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
Currency | US Dollars |
Share Price | $ 52.00 |
Change Today | $ 0.50 |
% Change | 0.97 % |
52 Week High | $58.62 |
52 Week Low | $29.84 |
Volume | 1,875,444 |
Shares Issued | 55.37m |
Market Cap | $2,879.40m |
RiskGrade | 332 |
Strong Buy | 4 |
Buy | 12 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
16:00 | 201,293 @ $52.00 |
15:59 | 100 @ $52.02 |
15:59 | 100 @ $52.00 |
15:59 | 100 @ $52.02 |
15:59 | 200 @ $52.01 |
You are here: research